INEX

INEX is a Canadian biopharmaceutical company developing and commercializing proprietary drugs and drug delivery systems to improve the treatment of cancer. INEX does not yet have products on the market. INEX’s lead product is Marqibo™ (sphingosomal vincristine), a proprietary drug comprised of the widely used, off-patent, anticancer drug vincristine and the Company's drug delivery technology.

Contact Details: 200-8900 Glenlyon Parkway Burnaby British Columbia V5J 5J8 Canada Tel: 604.419.3200 Fax: 604.419.3201 Email: info@inexpharm.com WWW: www.inexpharm.com/

Loading...

Recent Publications by INEX:
Methods for the preparation of protein-oligonucleotide-lipid constructs. A mixture of ionizable cationic lipids, steric barrier lipids, and...	13th July, 2006	Inex Pharmaceuticals Corporation, 100-8900 Glenlyon Parkway, Burnaby, BC,	Bioconjug Chem. 2006 Mar-Apr;17(2):451-8. DOI Direct Link
Micelles as intermediates in the preparation of protein-liposome conjugates. A method for preparing protein-liposome conjugates based on micelles as...	13th July, 2006	Inex Pharmaceuticals Corporation, 100-8900 Glenlyon Parkway, Burnaby, BC,	Bioconjug Chem. 2006 Mar-Apr;17(2):438-50. DOI Direct Link
Reliability of preparation procedure for sphingosomal vincristine. PURPOSE: The reliability of the preparation procedure for sphingosomal...	31st December, 2005	Inex Pharmaceuticals Corporation, Burnaby, British Columbia, Canada.	Am J Health Syst Pharm. 2005 Aug 1;62(15):1606-12. DOI Direct Link
Optimization and characterization of a sphingomyelin/cholesterol liposome formulation of vinorelbine with promising antitumor activity. Vinorelbine (VRL) is a particularly lipophilic member of the vinca...	13th August, 2005	Inex Pharmaceuticals Corporation, 200-8900 Glenlyon Parkway, Glenlyon	J Pharm Sci. 2005 May;94(5):1024-38. DOI Direct Link
Immunogenicity and rapid blood clearance of liposomes containing polyethylene glycol-lipid conjugates and nucleic Acid. Polyethylene glycol (PEG) is used widely in the pharmaceutical industry to...	6th April, 2005	Inex Pharmaceuticals Corporation, 100-8900 Glenlyon Parkway, Burnaby, BC,	J Pharmacol Exp Ther. 2005 Mar;312(3):1020-6. Epub 2004 Nov 3. DOI Direct Link
→View more INEX research publications.

INEX Patents:
US Patent No.	Title
7247316	Compositions and methods for treating lymphoma
5976567	Lipid-nucleic acid particles prepared via a hydrophobic lipid-nucleic acid complex intermediate and use for gene transfer
5965542	Use of temperature to control the size of cationic liposome/plasmid DNA complexes
5926556	Systems and methods for identifying a molded container
5926268	System and method for stress detection in a molded container
→View more INEX patents.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 333 times since April 2007, the link to the organisation's website has been followed 64 times

Recent Search Terms used to find this page: 100 - 8900 Glenlyon Parkway | inex singapore | inex pharmaceutical annual report archives | inex pharmaceutical annual report archives | .

Search for more companies in Burnaby

Search for more companies in British Columbia

This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for INEX